Skip to content

Morphing Machines secured ₹38.36 crore in a series A funding round led by IAN Alpha Fund

Morphing Machines secured ₹38.36 crore in a series A funding round led by IAN Alpha Fund
Morphing Machines Secures ₹38.36 Crore

SUMMARY

Morphing Machines is a Bengaluru-based fabless semiconductor IP firm that has managed to close a Series A round of funding, raising ₹38.36 crore of capital. This is a huge investment that will help the company hasten in coming up with groundbreaking technologies that will push the traditional limits of computing. Morphing Machines, a creation of almost 20 years of innovative work at the highly regarded Indian Institute of Science (IISc), is a significant success story in India’s booming Deep-tech economy, making a decade of academic advances commercially viable semiconductor technology.

Investors involved in the funding round

The IAN Alpha Fund was one of the leading participants in the investment round, which was an indication of a high level of institutional trust in the technology of the company and its market strategy. As evidence of how strong the vision of Morphing Machines was, other big investors, such as Speciale Invest, IvyCap Ventures, and Navam Capital, were involved in the round.

The ability to attract this capital by the company justifies its intention of providing high-performance and flexible computing solutions, which are not currently available in the market, currently in the hands of the global giants in the industry. Deepak Shapeti (Co-Founder & CEO), Dr. Ranjani Narayan (Founder and CTO), and Prof. S. K. Nandy (Founder and Chief Scientific Advisor) were co-founders of the company, whose conceptualization was based on extensive research, including time spent on the development of processors at various organisations such as DRDO and Safran Aerospace.

REDEFINE™, a flagship product of Morphing Machines

At the center of the innovation is the flagship product of Morphing Machines, REDEFINE™, which is a runtime reconfigurable manycore parallel compute processor. This next-generation architecture will be used to meet the growing requirements of compute agility, especially in high-demand industries like data centers and artificial intelligence (AI), whereby current hardware is failing to meet the fast-changing workload.

REDEFINE™ is designed to provide a much-needed technological gap by integrating the flexibility commonly available with a Field Programmable Gate Array (FPGA) with the speed of a high-performance Application-Specific Integrated Circuit (ASIC).

The technology of Morphing Machines enables the production of software-defined hardware, as opposed to the traditional semiconductor methods that can be cumbersome, lengthy, and expensive to implement the necessary changes and adjustments to current market conditions. This is an essential capability that allows REDEFINE™ The ability to scale to any workload, large and small, AI and analytics through high-performance computing, all with a fixed hardware fabric. 

Commercialization and global expansion

The Series A funding of ₹38.36 crore will be strategically invested in various areas that are important in ensuring that the company is fast-tracked towards commercialization and internationalization. One of the main areas is the promotion of the development and validation of the core technology.

The new capital will specifically be used to fund the very important process of constructing and testing the first silicon chip of the company, a major milestone, which is known as the proof-of-silicon. It will be used to continuously support the current product line and enhance the related software toolchain, which is critical for the easy adoption of the industry.

In addition to product development, Morphing machines are putting a lot of emphasis on the expansion of their operational capacities. The company intends to expand its staff by more than 90 individuals; its number has grown to 50 people. This staffing spurt will facilitate the intensive stages of design, verification, emulation, and primary commercial implementation.

The short-term objective is to initiate product demonstrations to target customers and get paid pilot projects with the data centers. The company is also looking to begin to expand into saturated global markets in 12 to 24 months, e.g., the US and Europe, where the demand for better computational efficiency and lower TCO is supreme.

Conclusion

Morphing Machines Series A financing round is a significant milestone towards India becoming a global leader in fabless semiconductor design. Such an investment not only confirms the innovative technology of the company but also highlights the maturity and increased commercial viability of the Deep-tech entrepreneurial environment in India, which is a crucial addition to the national semiconductor mission. 

Note: We at scoopearth take our ethics very seriously. More information about it can be found here.

Publish Your Startup Story